Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2001 1
2003 2
2004 7
2005 8
2006 8
2007 10
2008 10
2009 8
2010 13
2011 10
2012 12
2013 17
2014 29
2015 30
2016 35
2017 25
2018 19
2019 15
2020 29
2021 17
2022 21
2023 13
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

304 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators. Marso SP, et al. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15. N Engl J Med. 2016. PMID: 27633186 Free article. Clinical Trial.
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group. Pi-Sunyer X, et al. N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892. N Engl J Med. 2015. PMID: 26132939 Free article. Clinical Trial.
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, Ortiz RV, Wilding JPH, Skjøth TV, Manning LS, Pi-Sunyer X; SCALE Obesity Prediabetes NN8022-1839 Study Group. le Roux CW, et al. Lancet. 2017 Apr 8;389(10077):1399-1409. doi: 10.1016/S0140-6736(17)30069-7. Epub 2017 Feb 23. Lancet. 2017. PMID: 28237263 Free article. Clinical Trial.
Reply.
Sharman JE, O'Brien E, Alpert B, Delles C, Hecht Olsen M, McManus RJ, Padwal R, Parati G, Stergiou G; Lancet Commission on Hypertension Group. Sharman JE, et al. Among authors: padwal r. J Hypertens. 2020 Apr;38(4):775. doi: 10.1097/HJH.0000000000002345. J Hypertens. 2020. PMID: 32132435 No abstract available.
HEARTS en las Américas: un ejemplo mundial del uso de dispositivos automatizados de medición de la presión arterial validados clínicamente en la prevención y el manejo de las enfermedades cardiovasculares en entornos de atención primaria de salud.
Ordunez P, Lombardi C, Picone DS, Brady TM, Campbell NRC, Moran AE, Padwal R, Rosende A, Whelton PK, Sharman JE. Ordunez P, et al. Among authors: padwal r. Rev Panam Salud Publica. 2022 May 10;46:e50. doi: 10.26633/RPSP.2022.50. eCollection 2022. Rev Panam Salud Publica. 2022. PMID: 35573113 Free PMC article. Spanish.
Antihypertensive Medication Timing and Cardiovascular Events and Death: The BedMed Randomized Clinical Trial.
Garrison SR, Bakal JA, Kolber MR, Korownyk CS, Green LA, Kirkwood JEM, McAlister FA, Padwal RS, Lewanczuk R, Hill MD, Singer AG, Katz A, Kelmer MD, Gayayan A, Campbell FN, Vucenovic A, Archibald NR, Yeung JMS, Youngson ERE, McGrail K, O'Neill BG, Greiver M, Manca DP, Kraut RY, Wang T, Manns BJ, Mangin DA, MacLean C, McCormack J, Wong ST, Norris C, Allan GM. Garrison SR, et al. Among authors: padwal rs. JAMA. 2025 Jun 17;333(23):2061-2072. doi: 10.1001/jama.2025.4390. JAMA. 2025. PMID: 40354045 Clinical Trial.
Cuffless Blood Pressure Devices.
Bradley CK, Shimbo D, Colburn DA, Pugliese DN, Padwal R, Sia SK, Anstey DE. Bradley CK, et al. Among authors: padwal r. Am J Hypertens. 2022 May 10;35(5):380-387. doi: 10.1093/ajh/hpac017. Am J Hypertens. 2022. PMID: 35136906 Free PMC article. Review.
Confirmatory Testing for Primary Aldosteronism : A Study of Diagnostic Test Accuracy.
Leung AA, Padwal RS, Hundemer GL, Venos E, Campbell DJT, Holmes DT, Orton DJ, So CB, Przybojewski SJ, Caughlin CE, Pasieka JL, Rabi DM, Kline GA. Leung AA, et al. Among authors: padwal rs. Ann Intern Med. 2025 Jul;178(7):948-956. doi: 10.7326/ANNALS-24-03153. Epub 2025 May 6. Ann Intern Med. 2025. PMID: 40324193 Clinical Trial.
Glucagon-like peptide-1 agonists.
Padwal R. Padwal R. BMJ. 2012 Jan 10;344:d7282. doi: 10.1136/bmj.d7282. BMJ. 2012. PMID: 22236410 No abstract available.
Intraclass differences among antihypertensive drugs.
Feldman RD, Hussain Y, Kuyper LM, McAlister FA, Padwal RS, Tobe SW. Feldman RD, et al. Among authors: padwal rs. Annu Rev Pharmacol Toxicol. 2015;55:333-52. doi: 10.1146/annurev-pharmtox-010814-124446. Epub 2014 Sep 22. Annu Rev Pharmacol Toxicol. 2015. PMID: 25251994 Review.
304 results